Literature DB >> 9781541

Initial and follow-up screening for aneurysms in families with familial subarachnoid hemorrhage.

T W Raaymakers1, G J Rinkel, L M Ramos.   

Abstract

BACKGROUND AND
OBJECTIVE: In families with two or more relatives with subarachnoid hemorrhage (SAH), other first-degree relatives have an increased risk of SAH. We studied the presence of unruptured intracranial aneurysms in 125 members of 23 families with familial SAH, defined as two or more affected first-degree relatives, in a cross-sectional design.
METHODS: MR angiography was performed in 116 relatives; CT angiography was performed in the remaining 9 relatives because they had been treated for intracranial aneurysms in the past.
RESULTS: Overall, we found 16 aneurysms in 10 of 125 relatives (8%; 95% CI, 4 to 14%). Of the nine patients with previous surgery for ruptured or unruptured intracranial aneurysms, three had new aneurysms. Two factors were associated with a significantly higher risk of intracranial aneurysms: 1) a history of treatment for ruptured or unruptured intracranial aneurysms (relative risk 5.5; 95% CI, 1.7 to 17.8) and 2) having three or more affected relatives (relative risk 3.3; 95% CI, 1.0 to 10.6). Siblings tended to have a higher risk of intracranial aneurysms than did children of SAH patients, although the difference was not significant.
CONCLUSIONS: Because the yield is high, screening is recommended in first-degree members of families with familial SAH. Repeated screening should be considered in relatives who have been treated for familial intracranial aneurysms.

Entities:  

Mesh:

Year:  1998        PMID: 9781541     DOI: 10.1212/wnl.51.4.1125

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  18 in total

Review 1.  [Endovascular therapy for intracranial aneurysms].

Authors:  M Forsting; I Wanke
Journal:  Nervenarzt       Date:  2006-09       Impact factor: 1.214

Review 2.  Modern cross-sectional imaging in the diagnosis and follow-up of intracranial aneurysms.

Authors:  Karsten Papke; Friedhelm Brassel
Journal:  Eur Radiol       Date:  2006-01-14       Impact factor: 5.315

Review 3.  [Value of CT and MR angiography for diagnostics of intracranial aneurysms].

Authors:  C Roth
Journal:  Radiologe       Date:  2011-02       Impact factor: 0.635

4.  Long-term risk of aneurysmal subarachnoid hemorrhage after a negative aneurysm screen.

Authors:  Ingeborg Rasing; Ynte M Ruigrok; Paut Greebe; Birgitta K Velthuis; Theo D Witkamp; Marieke J H Wermer; Yvo B Roos; W Peter Vandertop; Gabriel J E Rinkel
Journal:  Neurology       Date:  2015-01-30       Impact factor: 9.910

5.  A balanced translocation truncates Neurotrimin in a family with intracranial and thoracic aortic aneurysm.

Authors:  Tiia M Luukkonen; Minna Pöyhönen; Aarno Palotie; Pekka Ellonen; Sonja Lagström; Joseph H Lee; Joseph D Terwilliger; Riitta Salonen; Teppo Varilo
Journal:  J Med Genet       Date:  2012-10       Impact factor: 6.318

6.  CT angiography in pediatric extremity trauma: preoperative evaluation prior to reconstructive surgery.

Authors:  Charles S Hsu; Jeffrey C Hellinger; Geoffrey D Rubin; James Chang
Journal:  Hand (N Y)       Date:  2007-11-07

7.  Familial intracranial aneurysms.

Authors:  Jin Soo Lee; In Sung Park; Kyung Bum Park; Dong-Ho Kang; Chul Hee Lee; Soo Hyun Hwang
Journal:  J Korean Neurosurg Soc       Date:  2008-09-30

Review 8.  Treatment of unruptured intracranial aneurysms: surgery, coiling, or nothing?

Authors:  Joseph D Burns; Robert D Brown
Journal:  Curr Neurol Neurosci Rep       Date:  2009-01       Impact factor: 5.081

9.  Usefulness of MR imaging for the assessment of nonophthalmic paraclinoid aneurysms.

Authors:  L Thines; J-Y Gauvrit; X Leclerc; D Le Gars; C Delmaire; J-P Pruvo; J-P Lejeune
Journal:  AJNR Am J Neuroradiol       Date:  2007-10-09       Impact factor: 3.825

10.  Value of CT angiography for the detection of intracranial vascular lesions in patients with acute severe headache.

Authors:  Ari Han; Dae Young Yoon; Eun Soo Kim; Heung Cheol Kim; Byung-Moon Cho; Jong Young Lee
Journal:  Eur Radiol       Date:  2012-12-21       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.